Latin America Ophthalmology Therapeutics Market by Indication (Glaucoma, Dry Eye Syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Macular Edema and Allergic Conjunctivitis) by End User (Hospitals, Eye Clinics, Diagnostic Centres and Patients), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Latin America Ophthalmology Therapeutics Market by Indication (Glaucoma, Dry Eye Syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Macular Edema and Allergic Conjunctivitis) by End User (Hospitals, Eye Clinics, Diagnostic Centres and Patients), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1110 | Pages: 137 | November 2016 | Region: Latin America


Latin America Ophthalmology Therapeutics Market was worth $2.68 billion in 2016 and estimated to be growing at a CAGR of 7.9%, to reach $3.91 billion by 2021. The market is showcasing evident potential in the mentioned forecasting period. Ophthalmology is the branch of medicine concerned with the management of eye defects and diseases.

Latin America market for Ophthalmology Therapeutics is driven by the growing prevalence for vision impairment. Prevalence of vision impairment varies from 1.1% in Argentina to 4.1% in Guatemala in people aged 50 years and above, with the major cause being cataract. Advancements in technology, increasing geriatric population across the continent are some of the key driving factors for the market. However, limited awareness about the various diseases associated with ophthalmology is a major restraint posed by the market. Unclear reimbursement policies are also one of the major restraint for the market growth.

Latin America Ophthalmology Therapeutics market is broadly Segmented into Indication and End User. By indication Latin America Ophthalmology Therapeutics market is sub-segmented into Glaucoma, Dry Eye Syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Macular Edema and Allergic Conjunctivitis. Glaucoma is the largest indication segment accounting for a share of approximately XX% followed by AMD with a share of XX%. On the basis of end User, the market is segmented into Hospitals, Eye Clinics, Diagnostic Centres and Patients. Geographically, Latin America Ophthalmology Therapeutics market is analysed under various regions namely Brazil, Argentina and Mexico. Within Latin America, Brazil is the largest market for Ophthalmology Therapeutic devices accounting for a share of approximately XX%.

Pfizer Inc., Allergan Inc., Alcon Inc., Merck & co. Inc. and Roche are the major players in the market accounting for a share of approximately XX%. Other major companies covered in the report are Valeant, Regeneron, Santen, Bayer, Senju, Lpath and Eye Gate Pharmaceuticals

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Indication                              

                                5.1.1 Glaucoma

                                5.1.2 Dry Eye Syndrome

                                5.1.3 Diabetic Retinopathy         

                                5.1.4 Retinal Vein Occlusion        

                                5.1.5 Age-Related Macular Degeneration (AMD)

                                5.1.6 Macular Edema    

                                5.1.7 Allergic Conjunctivitis         

                5.2 By End User               

                                5.2.1 Hospitals  

                                5.2.2 Eye Clinics

                                5.2.3 Diagnostic Centers              

                                5.2.4 Patients   

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7. Pipeline Product Analysis                                        

                7.1 Overview                    

                7.2 Pipeline Development Landscape                     

                7.3 Molecular Targets in the Pipeline                      

                7.4 Clinical Trials                              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target               

8.Strategic Analysis                                        

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

9.Market Leaders' Analysis                                          

                9.1 Allergan, Inc.                              

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Financial analysis  

                                9.1.4 Recent Developments       

                                9.1.5 SWOT analysis       

                                9.1.6 Analyst View          

                9.2 Merck & Co Inc                         

                9.3 Pfizer                            

                9.4 Roche                           

                9.5 Novartis (Alcon)                       

                9.6 Valeant                        

                9.7 Regeneron                 

                9.8 Santen                         

                9.9 Bayer                            

                9.10 Senju                          

                9.11 Lpath                          

                9.12 Eye Gate Pharmaceuticals                 

10.Competitive Landscape                                          

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

11.Market Outlook & Investment Opportunities                               

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Latin America Ophthalmology Therapeutics Market By Region, From 2016-2021 (USD Bllion)
  2. Latin America Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Bllion)
  3. Latin America Glaucoma Market By Region, From 2016-2021 (USD Bllion)
  4. Latin America Dry Eye Syndrome Market By Region, From 2016-2021 (USD Bllion)
  5. Latin America Diabetic Retinopathy Market By Region, From 2016-2021 (USD Bllion)
  6. Latin America Retinal Vein Occlusion Market By Region, From 2016-2021 (USD Bllion)
  7. Latin America Age-Related Macular Degeneration (AMD) Market By Region, From 2016-2021 (USD Bllion)
  8. Latin America Macular Edema Market By Region, From 2016-2021 (USD Bllion)
  9. Latin America Allergic Conjunctivitis Market By Region, From 2016-2021 (USD Bllion)
  10. Latin America Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Bllion)
  11. Latin America Hospitals Market By Region, From 2016-2021 (USD Bllion)
  12. Latin America Eye Clinics Market By Region, From 2016-2021 (USD Bllion)
  13. Latin America Diagnostic Centers Market By Region, From 2016-2021 (USD Bllion)
  14. Latin America Patients Market By Region, From 2016-2021 (USD Bllion)
  15. Brazil Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Bllion)
  16. Brazil Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Bllion)
  17. Argentina Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Bllion)
  18. Argentina Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Bllion)
  19. Mexico Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Bllion)
  20. Mexico Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Bllion)
Middle East And Africa Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combinatio...
Latin America Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, ...
Asia Pacific Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, H...
Europe Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, Hormona...
North America Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, ...
Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, Hormonal Agent...
Middle East And Africa Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxoru...
Latin America Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Be...
Asia Pacific Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bev...
Europe Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bevacizum...
North America Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Be...
Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bevacizumab, Erl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.